104 related articles for article (PubMed ID: 22397456)
1. HSPA2 overexpression protects V79 fibroblasts against bortezomib-induced apoptosis.
Filipczak PT; Piglowski W; Glowala-Kosinska M; Krawczyk Z; Scieglinska D
Biochem Cell Biol; 2012 Apr; 90(2):224-31. PubMed ID: 22397456
[TBL] [Abstract][Full Text] [Related]
2. Cooperative cytotoxicity of proteasome inhibitors and tumor necrosis factor-related apoptosis-inducing ligand in chemoresistant Bcl-2-overexpressing cells.
Nencioni A; Wille L; Dal Bello G; Boy D; Cirmena G; Wesselborg S; Belka C; Brossart P; Patrone F; Ballestrero A
Clin Cancer Res; 2005 Jun; 11(11):4259-65. PubMed ID: 15930365
[TBL] [Abstract][Full Text] [Related]
3. Investigation of the eIF2alpha phosphorylation mechanism in response to proteasome inhibition in melanoma and breast cancer cells.
Yerlikaya A; DoKudur H
Mol Biol (Mosk); 2010; 44(5):859-66. PubMed ID: 21090173
[TBL] [Abstract][Full Text] [Related]
4. Functional redundancy of HSPA1, HSPA2 and other HSPA proteins in non-small cell lung carcinoma (NSCLC); an implication for NSCLC treatment.
Sojka DR; Gogler-Pigłowska A; Vydra N; Cortez AJ; Filipczak PT; Krawczyk Z; Scieglinska D
Sci Rep; 2019 Oct; 9(1):14394. PubMed ID: 31591429
[TBL] [Abstract][Full Text] [Related]
5. Molecular sequelae of proteasome inhibition in human multiple myeloma cells.
Mitsiades N; Mitsiades CS; Poulaki V; Chauhan D; Fanourakis G; Gu X; Bailey C; Joseph M; Libermann TA; Treon SP; Munshi NC; Richardson PG; Hideshima T; Anderson KC
Proc Natl Acad Sci U S A; 2002 Oct; 99(22):14374-9. PubMed ID: 12391322
[TBL] [Abstract][Full Text] [Related]
6. The TRAIL apoptotic pathway mediates proteasome inhibitor induced apoptosis in primary chronic lymphocytic leukemia cells.
Kabore AF; Sun J; Hu X; McCrea K; Johnston JB; Gibson SB
Apoptosis; 2006 Jul; 11(7):1175-93. PubMed ID: 16699949
[TBL] [Abstract][Full Text] [Related]
7. Efficient induction of apoptosis by proteasome inhibitor: bortezomib in the human breast cancer cell line MDA-MB-231.
Krętowski R; Borzym-Kluczyk M; Cechowska-Pasko M
Mol Cell Biochem; 2014 Apr; 389(1-2):177-85. PubMed ID: 24385108
[TBL] [Abstract][Full Text] [Related]
8. TNF potentiates anticancer activity of bortezomib (Velcade) through reduced expression of proteasome subunits and dysregulation of unfolded protein response.
Nowis D; McConnell EJ; Dierlam L; Palamarchuk A; Lass A; Wójcik C
Int J Cancer; 2007 Jul; 121(2):431-41. PubMed ID: 17373661
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of HSPA1 and HSPA2 proteins in human tissues; tissue microarray-based immunohistochemical study.
Scieglinska D; Piglowski W; Chekan M; Mazurek A; Krawczyk Z
Histochem Cell Biol; 2011 Apr; 135(4):337-50. PubMed ID: 21373891
[TBL] [Abstract][Full Text] [Related]
10. Antioxidants block proteasome inhibitor function in endometrial carcinoma cells.
Llobet D; Eritja N; Encinas M; Sorolla A; Yeramian A; Schoenenberger JA; Llombart-Cussac A; Marti RM; Matias-Guiu X; Dolcet X
Anticancer Drugs; 2008 Feb; 19(2):115-24. PubMed ID: 18176107
[TBL] [Abstract][Full Text] [Related]
11. Blockade of Hsp27 overcomes Bortezomib/proteasome inhibitor PS-341 resistance in lymphoma cells.
Chauhan D; Li G; Shringarpure R; Podar K; Ohtake Y; Hideshima T; Anderson KC
Cancer Res; 2003 Oct; 63(19):6174-7. PubMed ID: 14559800
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of the Heat Shock Protein A (HSPA) Family Potentiates the Anticancer Effects of Manumycin A.
Sojka DR; Hasterok S; Vydra N; Toma-Jonik A; Wieczorek A; Gogler-Pigłowska A; Scieglinska D
Cells; 2021 Jun; 10(6):. PubMed ID: 34200371
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia enhances the senescence effect of bortezomib--the proteasome inhibitor--on human skin fibroblasts.
Krętowski R; Borzym-Kluczyk M; Cechowska-Pasko M
Biomed Res Int; 2014; 2014():196249. PubMed ID: 24605321
[TBL] [Abstract][Full Text] [Related]
14. The proteasome inhibitor bortezomib induces apoptosis in human retinoblastoma cell lines in vitro.
Poulaki V; Mitsiades CS; Kotoula V; Negri J; McMillin D; Miller JW; Mitsiades N
Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4706-19. PubMed ID: 17898295
[TBL] [Abstract][Full Text] [Related]
15. The HspA2 protein localizes in nucleoli and centrosomes of heat shocked cancer cells.
Scieglińska D; Pigłowski W; Mazurek A; Małusecka E; Zebracka J; Filipczak P; Krawczyk Z
J Cell Biochem; 2008 Aug; 104(6):2193-206. PubMed ID: 18452162
[TBL] [Abstract][Full Text] [Related]
16. Bik/NBK accumulation correlates with apoptosis-induction by bortezomib (PS-341, Velcade) and other proteasome inhibitors.
Zhu H; Zhang L; Dong F; Guo W; Wu S; Teraishi F; Davis JJ; Chiao PJ; Fang B
Oncogene; 2005 Jul; 24(31):4993-9. PubMed ID: 15824729
[TBL] [Abstract][Full Text] [Related]
17. Synergistic induction of oxidative injury and apoptosis in human multiple myeloma cells by the proteasome inhibitor bortezomib and histone deacetylase inhibitors.
Pei XY; Dai Y; Grant S
Clin Cancer Res; 2004 Jun; 10(11):3839-52. PubMed ID: 15173093
[TBL] [Abstract][Full Text] [Related]
18. Proteasome inhibitors potentiate leukemic cell apoptosis induced by the cyclin-dependent kinase inhibitor flavopiridol through a SAPK/JNK- and NF-kappaB-dependent process.
Dai Y; Rahmani M; Grant S
Oncogene; 2003 Oct; 22(46):7108-22. PubMed ID: 14562039
[TBL] [Abstract][Full Text] [Related]
19. Bortezomib inhibits PKR-like endoplasmic reticulum (ER) kinase and induces apoptosis via ER stress in human pancreatic cancer cells.
Nawrocki ST; Carew JS; Dunner K; Boise LH; Chiao PJ; Huang P; Abbruzzese JL; McConkey DJ
Cancer Res; 2005 Dec; 65(24):11510-9. PubMed ID: 16357160
[TBL] [Abstract][Full Text] [Related]
20. Expression, function, and regulation of the testis-enriched heat shock HSPA2 gene in rodents and humans.
Scieglinska D; Krawczyk Z
Cell Stress Chaperones; 2015 Mar; 20(2):221-35. PubMed ID: 25344376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
